Talking Euretina
A podcast by Whipsmart Media
60 Episodio
-
Episode 39: The Euretina Retinal Medicine Clinical Research Award
Pubblicato: 15/11/2023 -
Episode 38: Preview of Euretina Congress 2023
Pubblicato: 29/09/2023 -
Episode 37: Blind Faith - How RP patients are being targeted with bad science across the world
Pubblicato: 15/09/2023 -
Episode 36: The Ophthalmologica Lecture: Maximilian Pfau
Pubblicato: 01/09/2023 -
Episode 35: Treating PCV and Pachychoroid in Different Populations
Pubblicato: 15/08/2023 -
Episode 34: The Euretina Lecture: OncoVR
Pubblicato: 31/07/2023 -
Episode 33: The Euretina Innovation Summit - All You Need to Know
Pubblicato: 03/07/2023 -
Episode 32: Macular Holes and Glaucoma in Myopia
Pubblicato: 15/06/2023 -
Episode 31: Featured studies from the Ophthalmologica journal
Pubblicato: 18/05/2023 -
Episode 30: Intraocular Lymphoma: An Explainer
Pubblicato: 02/05/2023 -
Episode 29: How to get published in Euretina’s Journal, Ophthalmologica
Pubblicato: 14/04/2023 -
Episode 28: Diabetic Retinopathy - the latest exciting developments from across the world
Pubblicato: 30/03/2023 -
Episode 27: What do we mean by ”macula-off” RRD ... and how soon should we act?
Pubblicato: 14/03/2023 -
Episode 26: Tackling Acute Retinal Necrosis in Patients
Pubblicato: 01/03/2023 -
Episode 25: What individual patient data can tell us about treating macular holes
Pubblicato: 15/02/2023 -
Episode 24: Five Years after Approval of Voretigene Neparvovec – What is The Future of Retinal Gene Therapy?
Pubblicato: 06/02/2023 -
Episode 23: Everything You Need to Know About the New EBO-Euretina Exam
Pubblicato: 17/01/2023 -
Episode 22: Women in Retina
Pubblicato: 01/12/2022 -
Episode 21: What To Know About The Bad Guy In Myopia: Staphyloma
Pubblicato: 17/11/2022 -
Episode 20: A Deep Dive into the MOLES System
Pubblicato: 03/11/2022
Expert Discussions from the World of Retina: Exploring the latest developments in the field with world-renowned leaders. It will feature a monthly subspecialty journal club, panel discussions and interviews with key opinion leaders.
